Janney Montgomery Scott LLC Has $411,000 Position in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Janney Montgomery Scott LLC increased its position in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBEGet Rating) by 5.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 6,970 shares of the company’s stock after acquiring an additional 350 shares during the period. Janney Montgomery Scott LLC’s holdings in Invesco Dynamic Biotechnology & Genome ETF were worth $411,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Adirondack Trust Co. bought a new stake in Invesco Dynamic Biotechnology & Genome ETF during the third quarter worth approximately $41,000. Atria Wealth Solutions Inc. bought a new stake in Invesco Dynamic Biotechnology & Genome ETF during the first quarter worth approximately $221,000. Strategic Blueprint LLC bought a new stake in Invesco Dynamic Biotechnology & Genome ETF during the second quarter worth approximately $291,000. Raymond James & Associates boosted its position in Invesco Dynamic Biotechnology & Genome ETF by 13.3% during the third quarter. Raymond James & Associates now owns 6,210 shares of the company’s stock worth $366,000 after purchasing an additional 731 shares during the period. Finally, Citadel Advisors LLC boosted its position in Invesco Dynamic Biotechnology & Genome ETF by 153.4% during the second quarter. Citadel Advisors LLC now owns 10,843 shares of the company’s stock worth $626,000 after purchasing an additional 6,564 shares during the period.

Invesco Dynamic Biotechnology & Genome ETF Stock Down 0.2 %

Shares of Invesco Dynamic Biotechnology & Genome ETF stock opened at $67.14 on Tuesday. The stock has a 50 day moving average price of $65.04 and a two-hundred day moving average price of $62.91. Invesco Dynamic Biotechnology & Genome ETF has a 12-month low of $51.39 and a 12-month high of $68.11.

Invesco Dynamic Biotechnology & Genome ETF Profile

(Get Rating)

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Featured Stories

Want to see what other hedge funds are holding PBE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBEGet Rating).

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.